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Abstract
Vitamin C is known as a potent antioxidant. We studied vitamin C as a radioprotec-
tive agent, focusing on its antioxidative effect. When the body is exposed to radiation, 
free radicals and reactive oxygen species (ROS) are produced and oxidize cell compo-
nents, resulting in cell damage. Vitamin C has the potential to scavenge these radical 
products, thereby protecting against radiation-induced cell damage. We investigated 
the effects of vitamin C on radiation-induced gastrointestinal (GI) syndrome in mice. 
The mice received whole-body irradiation followed by bone marrow transplantation 24 
h after exposure. Despite avoiding bone marrow failure, the mice eventually died of GI 
syndrome. Pretreatment with per os administration of high-dose vitamin C effectively 
mitigated radiation-induced GI syndrome and improved mouse survivals, while per os 
post-treatment with vitamin C was ineffective, presumably due to impaired absorption 
from the radiation-damaged intestine. We also investigated the effect of post-exposure 
treatment with intraperitoneal administration of vitamin C on radiation-induced bone 
marrow dysfunction in mice. Intraperitoneal administration with high-dose vitamin C, 
even at 24 h after whole-body irradiation, was still effective in avoiding bone marrow 
dysfunction, thereby increasing mouse survival after radiation. In conclusion, adminis-
tration of high-dose vitamin C effectively reduced the radiation lethality in mice.
Keywords: antioxidant, radioprotectant, acute radiation syndrome, gastrointestinal 
syndrome, hematopoietic syndrome
1. Introduction
Since the discovery of radiation at the end of nineteenth century, radiation has been used in 
various fields, such as medicine, industrials, and agriculture among others. While such efforts 
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
have dramatically improved our level of living, radiation has also unfortunately been used to 
develop nuclear weapons. In addition, accidents have occurred at nuclear power plants that 
have resulted in catastrophic disasters [1–5]. Because of the accident at Fukushima Dai-ichi 
Nuclear Power Plant in Japan, many residents near the nuclear plant had to be evacuated and 
still cannot return to their homes [6].
Ionizing radiation affects the human body in two ways. It affects the body directly by cutting 
DNA chains, resulting in cell injuries. To reduce the direct radiation damage, lead is used to 
protect from gamma rays, and water or boron is also used to protect from neutrons. Physical 
protection is essential to prevent the direct effects of radiation. It also affects the body indi-
rectly, as when radiation hits water molecules in host cells, it produces large amounts of free 
radicals and reactive oxygen species (ROS), which then oxidize the cell components, resulting 
in cell injuries [7–10] (Figure 1).
To reduce/mitigate the indirect effects of radiation, it is essential to scavenge the generated 
free radicals or ROS [11, 12]. As host cells have abundant antioxidative enzymes by nature, 
free radicals and ROS generated under normal conditions are easily scavenged. However, if a 
body is exposed to radiation and exaggerated amounts of free radicals and ROS are produced, 
they cannot be entirely scavenged by intrinsic antioxidative enzymes. In such a situation, the 
administration of an antioxidative product can facilitate scavenging and prevent cell damage 
due to radiation. Many antioxidative products are reported to have radioprotective effects 
[13–17]. In this section, we describe the radioprotective effects of vitamin C, which is one of 
the strongest antioxidative agents [18–20] (Figure 1).
Vitamin C was originally discovered as a medical treatment for scurvy. It has several pharma-
cological actions, including an antioxidative effect. Nowadays, vitamin C is widely used as 
an additive in many foods. Although most animals can synthetize vitamin C by themselves, 
some primates, including human have lost the ability to produce vitamin C and so need to 
consume it in some form [21, 22].
Figure 1. Our strategy for the protection against radiation injury.
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Acute radiation syndrome occurs when a host is exposed to high-dose radiation in a short 
period of time. This syndrome can develop even in animals (e.g., mice) that can synthe-
tize vitamin C by themselves, as deficiency of antioxidants necessarily occurs after massive 
radiation exposure. Hematological syndrome, gastrointestinal (GI) syndrome, and dema-
gogical syndrome are highly frequent symptoms. The pathophysiology of acute radiation 
syndrome is basically caused by a stem cell disorder, which has a short cycle of cell turn 
over [23, 24].
Our group investigated the antioxidative effect of vitamin C on irradiated hosts using a 
mouse model.
2. Effects of pretreatment with per os (p.o.) administration of vitamin C 
on GI syndrome in whole‐body‐irradiated mice
We investigated the effect of vitamin C on radiation-induced GI syndrome in mice receiv-
ing whole-body irradiation (WBI). We found that pretreatment with vitamin C significantly 
improved the GI syndrome, thereby rescuing mice that had undergone bone marrow trans-
plantation from lethal radiation exposure [18].
2.1. Bone marrow transplantation alone cannot rescue mice from WBI at 14 Grays
When the mice were exposed to WBI at 6–14 Gray (Gy), 80% of mice survived after WBI at 
6 Gy, but no mice survived at doses of ≥8 Grays (Gy) (Figure 2A). However, when the mice 
received bone marrow transplantation (BMT) at 24 h after WBI, their mortality were drasti-
cally reduced and most mice survived (8 and 10 Gy, 100% survival; 12 Gy, 75% survival). 
After exposure of WBI at 8–12 Gy, the mice presumably died of bone marrow dysfunction, 
namely hematopoietic syndrome, and thereby BMT was effective in these mice. Nevertheless, 
BMT was not effective in the mice after WBI at 14 Gy (Figure 2B).
Figure 2. The mouse survival after WBI (A) and the effect of BMT on the survival after WBI (B) [18].
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2.2. Whole‐body‐irradiated mice at 14 Gy showed marked denudation of the intestinal 
mucosa and bone marrow aplasia
By the pathological examination, severe bone marrow aplasia was observed in mice at 7 days 
after WBI at 8 Gy compared to unirradiated control mice (0 Gy) (Figures 3A‐a, B‐a), although 
their intestinal mucosae were still intact even after 8 Gy radiation exposure (Figures 3A‐b, 
c, B‐b, c). However, when the mice were expose to WBI at 14 Gy, marked denudation of the 
intestinal mucosae were observed in them at 7 days after irradiation (Figures 3C‐b, c, arrow-
heads) accompanied with severe bone marrow aplasia (Figure 3C‐a). These mice suffered 
from the radiation-induced GI damage and presumably died of this GI damage after WBI at 
14 Gy, despite rescuing bone marrow failure by BMT.
2.3. Pretreatment but not posttreatment with vitamin C improved the mouse survival after 
14‐Gy WBI, in combination with BMT
To examine the dose response effects of vitamin C on the irradiated mice, we p.o. adminis-
tered 1.5, 15, 150 and 1500 mg/kg/day of vitamin C for 3 days before 14-Gy WBI to mice, fol-
lowed by BMT at 24 h after radiation. Pretreatment with 150 mg/kg/day of vitamin C was able 
to rescue some subjected mice (42% survival), while other doses of pretreatment with vitamin C 
Figure 3. Radiation-induced damage to the bone marrow and small intestine in mice 7 days after radiation [18].
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rescued no mice. Pretreatment with 1500 mg/kg/day of vitamin C also did not improve the 
mouse survival after WBI at 14 Gy. Such a massive administration of vitamin C may be con-
versely harmful for the host. We next studied the effect of posttreatment with vitamin C on 
the irradiated mice. Mice were p.o. administered with 150 mg/kg/day of vitamin C for 3 days 
after 14-Gy WBI and received BMT. Posttreatment with vitamin C did not affect the survival 
(0% survival) (Figure 4), although the pretreatment with the same doses of vitamin C was 
effective. When the mice were only pretreated with vitamin C and did not receive BMT, no 
mice survived after 14-Gy WBI (Figure 4). Of note: these mice died of bone marrow aplasia 
after radiation, not GI damage.
2.4. Pretreatment with vitamin C markedly improved the radiation‐induced intestinal 
damage, thereby rescuing mice from lethal WBI at 14 Gy, in combination with BMT
BMT following 14-Gy WBI remarkably improved bone marrow aplasia in the mice 7 days 
after radiation. However, these mice showed severe degenerative changes in the intes-
tinal mucosa (Figures 5A‐a, b). Pretreated with vitamin C for 3 days before 14-Gy WBI 
without BMT markedly improved the mucosal degeneration in the intestine but did not 
improve the bone marrow aplasia in mice (Figures 5B‐a, b). Notably, when mice were 
pretreated with vitamin C and received BMT following 14-Gy WBI, marked improve-
ments in both bone marrow aplasia and intestinal mucosal degeneration were noted 
(Figure 5C‐b).
2.5. Pretreatment with vitamin C prevented the intestinal tissue damage of the mice 
receiving 14‐Gy WBI followed by BMT
The mice showed significantly lower villus heights and crypt counts per circumference in 
the intestine after 14-Gy WBI (but not those receiving 8-Gy WBI) (Figure 6A, B). Although 
Figure 4. The effect of pre and posttreatment with vitamin C on the mouse survival after WBI [18].
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Figure 6. Villus height (A), and crypt counts (B) of the small intestine in mice. The tissue vitamin C levels in the small 
intestine (C), and the production of free radical metabolites in mice irradiated at 14 Gy (D) [18].
Figure 5. The effect of pretreatment with vitamin C or BMT following WBI on the bone marrow or small intestine in 
irradiated mice [18].
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treatment with BMT alone following 14-Gy WBI did not affect these degenerative changes, 
pretreatment with vitamin C markedly improved them (Figure 6A, B). Both the mice that 
were pretreated with vitamin C and received BMT following 14-Gy WBI also showed signifi-
cant improvements (Figure 6A, B).
2.6. Oral administration of vitamin C increased the tissue concentration of vitamin C in 
the small intestine
Per os administration of vitamin C for 3 days significantly increased the plasma concen-
trations of vitamin C in the treated mice than that of untreated controls (57 ± 11 versus 
30 ± 8 µ/mL, P < 0.05). Next, the vitamin C levels in tissues of small intestine were exam-
ined. To measure vitamin C levels in tissue of small intestine, a sample of small intestine 
(0.7 g) was removed from each mouse immediately after sacrifice and homogenized in 
5.4% metaphosphoric acid (9.8 g). Vitamin C levels of the homogenate supernatant were 
measured in the SRL laboratory (Tokyo, Japan) using high performance liquid chroma-
tography (HPLC). Pretreatment with vitamin C significantly increased the tissue concen-
trations of vitamin C in the small intestine just before radiation (Figure 6C). Interestingly, 
the tissue vitamin C levels were decreased at 1 h after radiation in not only vitamin C-
pretreated mice but also in untreated control mice (Figure 6C), indicating the critical 
consumption of tissue vitamin C by irradiation. Nevertheless, the mice pretreated with 
vitamin C still showed significantly higher tissue vitamin C levels than the untreated 
control mice (Figure 6C).
2.7. Pretreatment with vitamin C suppressed a radiation‐induced increase in the free 
radical metabolites in mouse plasma
To measure free radical metabolites in the plasma, we used the d-ROMs test (Diacron, 
Grosseto, Italy). It is a spectrophotometric method that assesses overall oxidative stress by 
measuring total hydroperoxide levels, given that hydroperoxides are intermediate oxidative 
products of lipids, peptides, and amino acids. We diluted 0.02 mL plasma in 1 mL acetate-
buffered solution. Hydroperoxide groups react with the transition metal ions liberated from 
the proteins in the acidic medium, and are converted to alkoxyl and peroxyl radicals accord-
ing to the Fenton reaction. These newly formed radicals, the quantities of which are directly 
proportional to those of the peroxides, were trapped chemically with 0.02 mL chromogen 
(N,N-diethyl-para-phenylenediamine), leading to the formation of a radical cation of this 
chromogen. The purple color resulting from this reaction over time was monitored in a spec-
trophotometer (Wismarll FRAS4, Tokyo, Japan) at 505 nm. The results of this method were 
expressed in conventional units (Carratelli units [UCarr]). Although free radical metabolites 
gradually increased in the plasma of untreated mice after radiation, pretreatment with vita-
min C significantly suppressed the increase in free radical metabolites at 4 and 7 days after 
radiation (Figure 6D). Posttreatment with vitamin C did not suppress the increase in free 
radical metabolites in mice.
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2.8. Pretreatment with vitamin C suppressed the radiation‐induced DNA damage in the 
crypt epithelial cells of the mouse’s small intestine
To examine the effect of pretreatment with vitamin C on the DNA damage in the mouse’s 
small intestine after WBI, antisingle stranded (ss) DNA was stained in the samples of small 
intestine, using polyclonal rabbit anti-ssDNA (A4506, DAKO, Glostrup, Denmark). In the mice 
without vitamin C pretreatment, the number of positive-stained cells for ssDNA increased in 
the epithelial crypts of the small intestine at 6 h after radiation and further increased at 24 h 
(Figure 7). In contrast, pretreatment with vitamin C significantly suppressed the increase in 
ssDNA positive-stained cells (Figure 7). In these mice, the epithelial cells in the crypts of small 
intestines only showed slightly positive staining for ssDNA at 24 h after radiation (Figure 7). 
Radiation-induced DNA damage of the mouse intestinal crypt cells may be effectively inhib-
ited by pretreatment with vitamin C.
3. The drastic effect of combination therapy with p.o. administration of 
vitamin C on the GI syndrome in mice receiving abdominal radiation
Although the survival rates of the mice receiving WBI at 14 Gy followed by BMT were 
increased by pretreatment with vitamin C, more than half of the mice still died of radiation-
induced GI damage. We therefore modified the administration manner of vitamin C in order 
to augment its radioprotective potential.
Figure 7. Radiation-induced DNA damage in the small intestines of mice irradiated with 14 Gy [18].
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We used an abdominal radiation model that was not complicated with bone marrow damage. 
Therefore, this model does not require murine sacrifice as a donor of bone marrow cells and is 
able to simplify the effects of the injury and treatment. In addition, abdominal radiation is fre-
quently performed on patients suffering from abdominal malignancy. It is therefore rational 
to research and develop an effective therapy for radiation-induced GI damage using a model 
of abdominal radiation. Although posttreatment with vitamin C alone was ineffective in our 
previous study, combined therapy of pre and posttreatment with vitamin C improved the sur-
vival rates slightly after abdominal radiation. We also added one-shot engulfment (boosting) 
of vitamin C 8 h before radiation in order to effectively increase the tissue vitamin C levels at 
the time of radiation exposure. As a result, we were able to elicit a remarkable radioprotective 
effect against radiation-induced lethal GI damage (100% survival) by combination therapy.
3.1. Abdominal radiation at 10–12 Gy was not lethal for mice, while the same radiation 
doses of WBI were lethal
As we described above, no mice survived after WBI at doses of ≥8 Gy (Figure 2A). In contrast, 
all mice survived after abdominal radiation even at 10 Gy, but no mice survived after abdomi-
nal radiation at ≥13 Gy (Figure 8).
Figure 8. The survival of mice after abdominal radiation [19].
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3.2. Abdominal radiation at 13 Gy caused lethal GI damage without inducing bone 
marrow aplasia
Severe bone marrow aplasia was observed in the lumbar vertebrae, the sternum, and the 
femur in mice at 7 days after WBI at 8 Gy (Figure 9). In contrast, the mice after abdomi-
nal radiation at 13 Gy retained a substantial number of bone marrow cells in the sternum 
and femur but not in the lumbar vertebrae that was directly exposed to a substantial dose 
during abdominal radiation (Figure 9). Bone marrow function may persist even after lethal 
abdominal radiation (13 Gy). However, marked denudation of the gastrointestinal mucosa, 
especially the ileac mucosa, was observed in the mice at 7 days after abdominal radiation at 
13 Gy (Figure 9). In contrast, the mice receiving lethal WBI at 8 Gy did not show such severe 
intestinal damage (Figure 9). Abdominal radiation thus induced severe GI damage but not 
extensive bone marrow damage in mice.
3.3. Abdominal radiation at 13 Gy restored the white blood cell (WBC) counts but not the 
plasma citrulline levels in mice
WBC counts transiently decreased at 1–3 days after abdominal radiation at 11–13 Gy but 
increased in mice beyond 5 days after abdominal radiation (Figure 10A). The mice receiving 
Figure 9. The pathological findings of the bone marrow and ileum in mice after abdominal radiation at 13 Gy or WBI 
at 8 Gy [19].
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WBI at 8 Gy did not show such a restoration of the WBC counts and eventually died of irre-
versible lethal bone marrow damage (Figure 10A). The red blood cell (RBC) counts as well as 
the hemoglobin (Hb) levels were also increased around 5–7 days after abdominal radiation at 
11 and 12 Gy (Figure 10B, C), whereas such increases in the RBC counts or Hb levels were not 
observed in the mice after 8-Gy WBI (Figure 10B, C). Interestingly, the mice showed severe 
anemia, as assessed by the RBC counts and Hb levels, at 10 days after abdominal radiation 
at 13 Gy due to gastrointestinal bleeding and subsequently died (Figure 10B, C). The platelet 
counts did not obviously decrease after abdominal radiation at 11–13 Gy, while in contrast, 
those counts markedly decrease after WBI at 8 Gy (Figure 10D). Abdominal radiation, even 
at 13 Gy (which is lethal), may not cause severe suppression of the bone marrow cells in mice. 
Plasma citrulline level was measured using a fully automated amino acid analyzer (JLC-500/
V2, Nihon Denshi, Tokyo, Japan). It can be reportedly utilized as a biomarker of intestinal 
failure after massive resection of the small intestine. Therefore, the changes in the plasma 
levels may be an effective biomarker of radiation-induced GI syndrome [19]. Although the 
plasma citrulline levels were decreased in mice around 3–7 days after abdominal radiation 
at 11 and 12 Gy, they recovered 10 days after radiation exposure (Figure 10E). However, the 
mice receiving abdominal radiation at 13 Gy did not show restoration of the citrulline levels at 
10 days (Figure 10E). Since their intestinal mucosae were also severely impaired at that point 
(Figure 9), the plasma citrulline levels after abdominal radiation may reflect the change in the 
intestinal degradation. In line with this finding, the mice receiving WBI at 8 Gy showed signifi-
cant restoration of the plasma citrulline levels at 5–7 days (Figure 10E) without any intestinal 
damage (Figure 9).
Figure 10. The changes in the hematological parameters and plasma citrulline levels after abdominal radiation [19].
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3.4. Combination therapy with vitamin C drastically improved the mouse survival after 
abdominal radiation
Per os administration of vitamin C for 3 days before irradiation (Plan I, Figure 11) rescued only 
20% of mice from lethal abdominal irradiation at 13 Gy (Figure 12). Engulfment of vitamin C at 
8 h before radiation (Plan II, Figure 11) also rescued 20% of mice from abdominal radiation at 13 Gy 
(Figure 12). We tried the engulfment of vitamin C at 2 h before radiation in the mice, but their sur-
vival was <10%, suggesting that an interval of 2 h was too short to sufficiently increase the vita-
min C levels in the mice. We next examined the p.o. administration of vitamin C for 3 days and 
engulfment 8 h before radiation in mice (Plan III, Figure 11). Nevertheless, the survivals of these 
mice were still 20% (Figure 12). As expectedly, posttreatment with p.o. administration of vitamin 
C was ineffective (0% survival, Figure 12). However interestingly, when we tried combination 
treatment before and after radiation in mice (Plan V, Figure 11), their survival rates increased to 
40% (Figure 12). Notably, when the one-shot engulfment (8 h before radiation) of vitamin C was 
added to the oral administration for 10 days before/after radiation (Plan VI, Figure 11), the mouse 
survival was drastically increased to 100% survival after abdominal radiation (Figure 12).
3.5. Combination therapy with vitamin C effectively increased the tissue vitamin C levels 
in the small intestine of mice
Pretreatment with vitamin C for 3 days before radiation significantly increased the vitamin C 
levels in the intestinal tissue just before radiation, and also the administration of engulfing 
Figure 11. The experimental design for abdominal radiation and the treatments with vitamin C [19].
Vitamin C
vitamin C at 8 h before radiation tended to increase the tissue vitamin C levels, but not signifi-
cantly (Table 1). Interestingly, boosted pretreatment with vitamin C (oral intake for 3 days and 
engulfment at 8 h before radiation) further increased the tissue vitamin C levels in the intestine 
just before radiation (Table 1). However, there were no significant differences in the plasma 
vitamin C levels among these mouse groups (Table 1). Boosted p.o. pretreatment with vitamin 
C effectively increased the tissue vitamin C levels in the small intestine just before radiation.
3.6. Combination therapy with vitamin C restored the intestinal damage while reducing 
the elevation of free radical metabolite levels after abdominal radiation in mice
Combination therapy with p.o. administration of vitamin C for 10 days before/after radiation 
and one-shot engulfment at 8 h before radiation (Plan VI, Figure 11) significantly restored 
the intestinal damage in mice after abdominal radiation at 13 Gy (Figure 13A). This combina-
tion therapy with vitamin C also suppressed the positive TUNEL (terminal deoxynucleotid-
yltransferase-mediated dUTP nick end labeling) staining in the ileac mucosa in mice at 12 h 
after abdominal radiation at 13 Gy (Figure 13B). TUNEL staining was performed using an 
in‐situ apoptosis detection kit (MK500, Takara, Tokyo Japan). Vitamin C may suppress the 
radiation-induced apoptosis in the intestinal mucosa. Consistently, combination therapy with 
vitamin C also restored the villus height of the ileac mucosa beyond 7 days after abdominal 
radiation (Figure 14A) and restored the plasma citrulline levels (Figure 14B). Thus, a certain 
relationship was suggested between the plasma citrulline levels and intestinal damage. This 
regiment of vitamin C treatment drastically improved the radiation-induced intestinal dam-
age, resulting in an improvement in mouse survival after lethal abdominal radiation
Figure 12. The effects of treatment with vitamin C on the survival of mice receiving abdominal radiation [19].
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Figure 13. The changes in the intestinal mucosa of the irradiated mice with or without vitamin C treatment [19].
Vitamin C levels
Groups Tissue level of the small intestine 
(mg/L)
Plasma (mg/L)
No treatment with vitamin C 22.8 ± 2.0 5.2 ± 0.5
Engulfment (8 h before) with 
vitamin C
27.1 ± 1.4 5.2 ± 0.9
Pretreatment (for 3 days) with 
vitamin C
30.5 ± 1.6 † 6.2 ± 0.7
Pretreatment (for 3days) + 
engulfment (8 h before) with 
vitamin C
36.1 ± 1.7 * 6.3 ± 0.6
Mice received the indicated treatments with vitamin C. The small intestine and plasma were obtained from the mice just 
before radiation. Data are shown as means ± SE (standard error) from n=5 in each group. *p<0.01 vs. no treatment and 
engulfment (8h) and p<0.05 vs. pretreatment (3 days), and †p<0.01 vs. no treatment [19]. 
Table 1. Vitamin C levels in the small intestine and plasma after the treatments with vitamin C.
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4. The effect of postexposure treatment with intraperitoneal 
administration of vitamin C on the bone marrow dysfunction in mice 
after WBI
Considering the practical applications of vitamin C, such as in treating those affected by 
nuclear accidents, postexposure treatment is crucial for patients suffering from radiation 
exposure. However, it can be difficult for the patients to take high-dose vitamin C orally after 
radiation exposure, because the GI tract may already be damaged by radiation. Intravenous 
(or intraperitoneal; in case of mice) administration is preferred.
We therefore investigated the effects of postexposure treatment with intraperitoneal (i.p.) 
vitamin C on mice after irradiation. We found that the postexposure treatment with vitamin 
C reduced radiation-induced apoptosis in bone marrow cells and restored the hematopoi-
etic function, thereby reducing the mortality in irradiated mice. Interestingly, postexposure 
treatment with vitamin C was effective even 24 h after radiation exposure. Large amounts 
of vitamin C (3 g/kg) were needed to improve the radiation-induced mortality in mice. We 
next examined the effects of divided i.p. administration of high-dose vitamin C. Divided i.p. 
administration with vitamin C (1.5 g/kg × 2, immediately after and 24 h after radiation) was 
effective in treating irradiated mice. The administration of high-dose vitamin C may be useful 
for mitigation therapy even after exposure [20].
4.1. Postexposure treatment with i.p. administration of vitamin C improved the survival 
of whole‐body‐irradiated mice
When the mice were exposed to 7 Gy-WBI, their survival rate was 67%. However, postexposure 
treatment with 3 g/kg of vitamin C immediately after WBI at 7 Gy rescued all of the subject 
mice (100% survival) (Figure 15A). Nevertheless, either 1 or 2 g/kg of vitamin C was ineffec-
tive (Figure 15A). A substantial dose of vitamin C (3 g/kg) was needed to induce a mitigating 
effect against radiation-induced lethality. This postexposure treatment with 3 g/kg of vitamin C 
Figure 14. The changes in the villus height and plasma citrulline levels in the irradiated Figure 14. mice with and without 
vitamin C treatment [19].
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Figure 15. The survival of mice that received postexposure treatment with vitamin C after WBI at 7 (A), 7.5 (B), and 8 
Gy (C) [20].
also significantly improved the mouse survival after 7.5-Gy WBI (Figure 15B). However, 
 treatment with 4.5 g/kg of vitamin C conversely reduced the mouse survival after 7.5-Gy WBI 
(Figure 15B). With this treatment, 60% of mice died within 1 day after vitamin C treatment fol-
lowing radiation. The massive administration of vitamin C may be harmful for these irradiated 
mice, as more than half of the mice died within 1 day of the administration of 4.5 g/kg vitamin 
C, even in the absence of irradiation (Figure 15B). As expectedly, pretreatment with 3 g/kg of 
vitamin C rescued 65% of mice after lethal 8-Gy WBI, although the postexposure treatment 
with vitamin C (3 g/kg) rescued 20% of mice (Figure 15C), confirming that pretreatment with 
vitamin C had a potent radioprotective effect. Postexposure treatment with 4 g/kg of vitamin C 
as well as 4.5 g/kg markedly reduced the mouse survival at 1 day after 8-Gy WBI (13 and 0%, 
respectively), suggesting a harmful effect due to the extremely high-dose of vitamin C.
4.2. Postexposure treatment with vitamin C restored the bone marrow functions in mice 
after WBI
Postexposure treatment with 3 g/kg of vitamin C did not restore the WBC counts, RBC counts, 
Hb levels, or platelet counts in mice until 14 days after WBI at 7.5 or 8 Gy, but markedly 
Vitamin C52
restored these hematological parameters at 3 weeks after WBI (Figure 16). Lethal 8-Gy WBI 
had severely damaged bone marrow cells at 14 days after radiation (Figure 17A, C). However, 
postexposure treatment with 3 g/kg vitamin C rescued a portion of the bone marrow cells 
from the lethal radiation at 14 days after exposure (Figure 17B, D), despite still suppression 
of hematological parameters (Figure 16, right column). Immunohistochemical staining of cas-
pase-3 was performed using polyclonal rabbit anticaspase-3 antibody (Asp175, Cell Signaling 
Technology, Inc. Danvers, MA). Caspase-3-positive cells increased in the bone marrow 6 h 
after WBI at 8 Gy (Figure 17E, indicated by arrows). However, postexposure treatment with 
3 g/kg of vitamin C reduced the caspase-3 positive cells (Figure 17F). Postexposure treatment 
with vitamin C may suppress radiation-induced apoptotic cell death in the bone marrow.
4.3. Postexposure treatment of vitamin C increased the plasma vitamin C and biological 
antioxidant potential (BAP) levels in mice after WBI
Intraperitoneal administration with 3 g/kg vitamin C markedly increased the plasma vitamin C 
levels in mice with and without 7.5-Gy WBI at 30 min and 1 h after administration (Table 2), and 
the levels were then decreased at 2 h (irradiated mice, 120 ± 38; nonirradiated mice, 188 ± 27 µg/L 
at 2 h). The vitamin C levels in the plasma were measured by the SRL laboratory (Tokyo, Japan) 
using HPLC. The ferric-reducing ability in plasma was also measured spectrophotometrically 
using the BAP test (Diacron, Grosseto, Italy). In brief, a colored solution containing ferric ions is 
reduced to ferrous ions by reduction of the sample, and the antioxidant activity of the sample is 
proportional to the measured decrease in absorbance. The BAP assays were performed on the 
FRAS 4 analyzer (Wismarll FRAS 4, Tokyo, Japan) according to the manufacturer’s protocols. 
Figure 16. Changes in hematological parameters after irradiation of mice [20].
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Figure 17. Histological findings in the bone marrow of irradiated mice [20].
Radiation Treatment Plasma vitamin C levels (μg/L) Plasma BAP levels (mMol/L)
30 min after 
administration
1 h after 
administration
30 min after 
administration
1 h after 
administration
7.5 Gy Vitamin C (+) 3659 ± 382* 1,878 ± 419* 30.1 ± 2.1* 5.7 ± 0.8*
Vitamin C (−) 2.6 ± 0.7 1.7 ± 0.2 3.1 ± 0.1 3.4 ± 0.1
Nonradiation Vitamin C (+) 3287 ± 520* 940 ± 128 28.3 ± 2.4* 5.3 ± 0.8
Vitamin C (−) 1.2 ± 0.2 3.0 ± 0.1
Mice received WBI at 7.5 Gy or did not. Subsequently, 3 g/kg of vitamin C or saline was administered to the mice. Data 
shown are mean ± SE from five mice.
* p < 0.01 vs. vitamin C (−) [20].
Table 2. Plasma levels of vitamin C after radiation with or without vitamin C treatment.
Vitamin C54
These plasma BAP levels were markedly increased at 30 min after i.p. administration with vita-
min C in both irradiated and nonirradiated mice (Table 2). Intraperitoneal administration of 
vitamin C potently induced antioxidant capability in mice, even after irradiation. Whereas, these 
increased plasma BAP levels reduced to normal levels in both irradiated and nonirradiated mice 
at 2 h after i.p. administration of vitamin C (Table 2).
4.4. Postexposure treatment of vitamin C at 24 h after radiation was still effective in 
irradiated mice
To examine how long we could delay postexposure treatment with vitamin C after radiation 
exposure, vitamin C was administered to mice at 1, 6, 12, 24, 36 or 48 h after 7.5-Gy WBI. As a 
result, treatment with vitamin C up to 24 h after radiation effectively increased the survival of 
irradiated mice, although the treatment beyond 36 h postirradiation was ineffective (Figure 18B).
4.5. Divided i.p. administration with vitamin C (1.5 g/kg × 2, immediately after and 24 h 
after radiation) was effective in irradiated mice
Considering a clinical application of vitamin C, a single administration with 3 g/kg of vitamin 
C appeared to be too high a dose for mice to tolerate, although nonirradiated mice did not 
die after this dose. The efficacy of two treatments of vitamin C was then examined (1.5 g/kg × 
2, immediately after radiation and 24 h after, 3 g/kg in total). This divided i.p. administration 
with vitamin C markedly increased the survival of mice after WBI at 7.5 Gy (Figure 19A), 
Figure 18. The mouse survival as a function of the time of postexposure treatment with vitamin C [20].
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despite either single injection with 1.5 g/kg of vitamin C immediately after or 24 h after radia-
tion was ineffective. In addition, divided i.p. administration with vitamin C (1.5 g/kg × 2) as 
well as a single administration (3 g/kg) suppressed the elevation of the plasma free radical 
metabolite levels after radiation (Figure 19B), suggesting that radiation-induced free radical 
productions may be effectively reduced.
5. Conclusions
Vitamin C is a strong antioxidative agent with potent radio-protective effects. In addition, vita-
min C is a water-soluble vitamin and can be easily and safely excreted into the urine and can be 
excessively ingested. When bodies are exposed to radiation, the exposure evokes free radicals 
and ROS, which oxidize cell components, resulting in impairment of host cells. Antioxidants 
such as vitamin C protect hosts from radiation damage by scavenging such radical products. 
However, large doses of vitamin C are required to induce this radio-protective effect. We 
treated irradiated mice with p.o. administration with 150 or 250 mg/kg/day of vitamin C for 
Figure 19. The survival of mice following one or two treatments with vitamin C (3 g/kg) after WBI and, plasma levels of 
free radical metabolites were also measured 7 and 14 days after WBI [20].
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7–10 days [18, 19]. We also delivered i.p. administration with 3 g/kg of vitamin C to mice for 
postexposure treatment [20]. Because the daily requirement of doses of vitamin C is several 
milligrams per kilogram order in humans, several hundred to thousand times the doses of 
vitamin C were administered p.o. or i.p. to the mice in our studies.
A number of reports have described high-dose vitamin C therapy for the common cold, ther-
mal injury, and malignant tumors, among other ailments [21, 25, 26]. In these reports, no 
severe side effects were observed by p.o. administration with high-dose vitamin C, although 
diarrhea or loose stool was occasionally noted. This is presumed to be osmotic diarrhea. In our 
unpublished data, when human volunteers took 5 g of vitamin C orally, approximately 7% of 
them had diarrhea or loose stool. The intravenous administration of high-dose vitamin C is 
widely used as a complementary and alternative medicine for various patients [27]. However, 
we should practice caution when administering gram-orders of vitamin C to patients [28]. 
Nephropathy due to oxalate, one of the main metabolites of vitamin C, has been reported in 
patients with renal impairment after the massive administration of vitamin C [29–31]. Patients 
with glucose-6-phosphate dehydrogenase deficiency also reportedly developed intravascular 
hemolysis after receiving massive administration of vitamin C [32, 33]. However, a recent 
clinical study has shown that the intravenous administration of 1.5 g/kg of vitamin C thrice 
weekly is safe and nontoxic in cancer patients, when patients with renal failure or glucose-6-
deficiency were excluded [34].
We believe that vitamin C is a practical radioprotectant, as it is not expensive to synthesize 
and does not induce serious side effects, even if administered at a high dose. Indeed, sev-
eral first responders dispatched to the Fukushima Dai-ichi Nuclear Power Plant Accident 
took vitamin C before their mission. Fortunately, no responders were exposed to high-dose 
radiation or developed acute radiation syndrome, but this prevented any evaluation of the 
effectiveness of vitamin C for preventing acute radiation syndrome; notably, though, no one 
reported any side effects.
If we use radiation or radioactive substance properly, it is an effective and a useful tool 
for us. However, fears still exist about misuse of this tool by someone with evil thought. 
In addition, we should always keep in mind that the human make mistakes without mal-
ice. We must prepare for radiological accidents without demanding any sacrifice by first 
responders.
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